Citations (62)
Keep up to date with the latest research on this topic with citation updates for this article.
Read on this site (14)
Young-Mi Ah, Jaekyu Shin & Ju-Yeun Lee. (2019) The association of angiotensin receptor blocker-based combination therapy with persistence and adherence in newly treated, uncomplicated hypertensive patients. Patient Preference and Adherence 13, pages 241-248.
Read now
Read now
Louise E Bartlett, Nicole L Pratt & Elizabeth E Roughead. (2018) Prior experience with cardiovascular medicines predicted longer persistence in people initiated to combinations of antihypertensive and lipid-lowering therapies: findings from two Australian cohorts. Patient Preference and Adherence 12, pages 835-843.
Read now
Read now
Luca Degli Esposti, Valentina Perrone, Chiara Veronesi, Marco Gambera, Giulio Nati, Francesco Perone, Paola Fausta Tagliabue, Stefano Buda & Claudio Borghi. (2018) Modifications in drug adherence after switch to fixed-dose combination of perindopril/amlodipine in clinical practice. Results of a large-scale Italian experience. The amlodipine-perindopril in real settings (AMPERES) study. Current Medical Research and Opinion 34:9, pages 1571-1577.
Read now
Read now
Caitlyn T Solem, Ahmed Shelbaya, Yin Wan, Chinmay G Deshpande, Jose Alvir & Elizabeth Pappadopulos. (2016) Analysis of treatment patterns and persistence on branded and generic medications in major depressive disorder using retrospective claims data. Neuropsychiatric Disease and Treatment 12, pages 2755-2764.
Read now
Read now
Adelaide Maria de Souza Antunes, Rafaela Di Sabato Guerrante, Jorge de Paula Costa Ávila, Flavia Maria Lins Mendes & Iolanda M. Fierro. (2016) Case study of patents related to captopril, Squibb’s first blockbuster. Expert Opinion on Therapeutic Patents 26:12, pages 1449-1457.
Read now
Read now
Luca Degli Esposti, Stefania Saragoni, Stefano Buda & Ezio Degli Esposti. (2014) Drug adherence to olmesartan/amlodipine fixed combination in an Italian clinical practice setting. ClinicoEconomics and Outcomes Research 6, pages 209-216.
Read now
Read now
Lin Xie, Feride Frech-Tamas, Elizabeth Marrett & Onur Baser. (2014) A medication adherence and persistence comparison of hypertensive patients treated with single-, double- and triple-pill combination therapy. Current Medical Research and Opinion 30:12, pages 2415-2422.
Read now
Read now
Steen Neldam, Helmut Schumacher, Sverre E. Kjeldsen & Joel M. Neutel. (2014) Telmisartan in combination with hydrochlorothiazide 12.5 mg for the management of patients with hypertension. Current Medical Research and Opinion 30:9, pages 1715-1724.
Read now
Read now
Natalie Schellack & Lucille Malan. (2014) An overview of fixed-dose combinations of antihypertensive drugs in South Africa. South African Family Practice 56:4, pages 206-211.
Read now
Read now
Julian Segura & Luis Miguel Ruilope. (2013) A review of the benefits of early treatment initiation with single-pill combinations of telmisartan with amlodipine or hydrochlorothiazide. Vascular Health and Risk Management 9, pages 521-528.
Read now
Read now
Danny H Sugimoto, Steven G Chrysant, Michael Melino, James Lee, Victor Fernandez & Reinilde Heyrman. (2013) The TRINITY Study: distribution of systolic blood pressure reductions. Integrated Blood Pressure Control 6, pages 89-99.
Read now
Read now
Addison A Taylor & Shawn Ragbir. (2012) Three in one: safety, efficacy, and patient acceptability of triple fixed-dose combination medicine in the management of hypertension. Patient Preference and Adherence 6, pages 555-563.
Read now
Read now
Sripal Bangalore & Ludwin Ley. (2012) Improving treatment adherence to antihypertensive therapy: the role of single-pill combinations. Expert Opinion on Pharmacotherapy 13:3, pages 345-355.
Read now
Read now
L. Breitscheidel, B. Ehlken, K. Kostev, M. S. A. Oberdiek, A. Sandberg & R. E. Schmieder. (2012) Real-life treatment patterns, compliance, persistence, and medication costs in patients with hypertension in Germany. Journal of Medical Economics 15:1, pages 155-165.
Read now
Read now
Articles from other publishers (48)
Qiran Wei, Jiting Zhou, Hongchao Li, Luying Wang, Yao Wu, Aixia Ma & Xin Guan. (2023) Medication adherence with fixed-dose versus free-equivalent combination therapies: Systematic review and meta-analysis. Frontiers in Pharmacology 14.
Crossref
Crossref
Eun-Seok Jeon, Sang Wook Lim, Seok-Yeon Kim, Hyoung-Mo Yang, Moo Hyun Kim, Moo-Yong Rhee, Seung Hwan Han, Jinho Shin, Kwang-il Kim, Jin-Ok Jeong, Ki Chul Sung, Geu Ru Hong, Hyung-Seop Kim, Kihwan Kwon, Tae-Soo Kang, Hae-Young Lee & Su-Eun Han. (2022) A randomized, double-blind, multicenter, phase III study on the efficacy and safety of a combination treatment involving fimasartan, amlodipine, rosuvastatin in patients with essential hypertension and dyslipidemia who fail to respond adequately to fimasartan monotherapy. Clinical Hypertension 28:1.
Crossref
Crossref
Apichard Sukonthasarn, Yook‐Chin Chia, Ji‐Guang Wang, Jennifer Nailes, Peera Buranakitjaroen, Huynh Van Minh, Narsingh Verma, Satoshi Hoshide, Jinho Shin, Yuda Turana, Jam Chin Tay, Boon Wee Teo, Saulat Siddique, Jorge Sison, Yu‐Qing Zhang, Tzung‐Dau Wang, Chen‐Huan Chen & Kazuomi Kario. (2020) The feasibility of polypill for cardiovascular disease prevention in Asian Population. The Journal of Clinical Hypertension 23:3, pages 545-555.
Crossref
Crossref
Anik R. Patel, Gail F. Schwartz, Joanna H. Campbell, Chi-Chang Chen, Catherine B. McGuiness, Jasjit K. Multani, Vanessa Shih & Oluwatosin U. Smith. (2021) Economic and Clinical Burden Associated With Intensification of Glaucoma Topical Therapy: A US Claims-based Analysis. Journal of Glaucoma 30:3, pages 242-250.
Crossref
Crossref
Gianfranco Parati, Sverre Kjeldsen, Antonio CocaWilliam C. Cushman & Jiguang Wang. (2021) Adherence to Single-Pill Versus Free-Equivalent Combination Therapy in Hypertension. Hypertension 77:2, pages 692-705.
Crossref
Crossref
Ana Baumgartner, Katarina Drame, Stijn Geutjens & Marja Airaksinen. (2020) Does the Polypill Improve Patient Adherence Compared to Its Individual Formulations? A Systematic Review. Pharmaceutics 12:2, pages 190.
Crossref
Crossref
Anna F. Dominiczak, Martine de Champvallins, Romualda Brzozowska-Villatte & Roland Asmar. (2019) Efficacy of a new single-pill combination of a thiazide-like diuretic and a calcium channel blocker (indapamide sustained release/amlodipine) in essential hypertension. Journal of Hypertension 37:11, pages 2280-2289.
Crossref
Crossref
Seung Jae Kim, Oh Deog Kwon, BeLong Cho, Seung-Won Oh, Cheol Min Lee & Ho-Chun Choi. (2019) Effects of combination drugs on antihypertensive medication adherence in a real-world setting: a Korean Nationwide Study. BMJ Open 9:6, pages e029862.
Crossref
Crossref
Sofa D. Alfian, Ivan S. Pradipta, Eelko Hak & Petra Denig. (2019) A systematic review finds inconsistency in the measures used to estimate adherence and persistence to multiple cardiometabolic medications. Journal of Clinical Epidemiology 108, pages 44-53.
Crossref
Crossref
Priti P. Pednekar, Tamás Ágh, Maria Malmenäs, Amit D. Raval, Bryan M. Bennett, Bijan J. Borah, David S. Hutchins, Elizabeth Manias, Allison F. Williams, Mickaël Hiligsmann, Adina Turcu-Stiolica, John E. Zeber, Lusine Abrahamyan, Thomas J. Bunz & Andrew M. Peterson. (2019) Methods for Measuring Multiple Medication Adherence: A Systematic Review–Report of the ISPOR Medication Adherence and Persistence Special Interest Group. Value in Health 22:2, pages 139-156.
Crossref
Crossref
Stelina Alkagiet & Konstantinos Tziomalos. (2018) Suboptimal Adherence to Antihypertensive Treatment: Causes and Management. The Open Hypertension Journal 10:1, pages 41-45.
Crossref
Crossref
Benoit Imbeault & Michel Vallée. (2018) Single-Pill Combinations in the Treatment of Hypertension in Adults: Beyond Convenience. Canadian Journal of Diabetes 42:2, pages 205-208.
Crossref
Crossref
Idir Hamdidouche, Vincent Jullien, Stéphane Laurent & Michel Azizi. 2018. Drug Adherence in Hypertension and Cardiovascular Protection. Drug Adherence in Hypertension and Cardiovascular Protection
185
197
.
Andrea L. Schaffer, Nicholas A. Buckley & Sallie-Anne Pearson. (2017) Who benefits from fixed-dose combinations? Two-year statin adherence trajectories in initiators of combined amlodipine/atorvastatin therapy. Pharmacoepidemiology and Drug Safety 26:12, pages 1465-1473.
Crossref
Crossref
Chen-Pei Ho, Jih-I Yeh, Shu-Hui Wen & Tony Jer-Fu Lee. (2017) Associations among medication regimen complexity, medical specialty, and medication possession ratio in newly diagnosed hypertensive patients. Medicine 96:45, pages e8497.
Crossref
Crossref
Jennifer S. Albrecht, Bilal Khokhar, Ting-Ying Huang, Yu-Jung Wei, Ilene Harris, Patience Moyo, Peter Hur, Susan W. Lehmann, Giora Netzer & Linda Simoni-Wastila. (2017) Adherence and healthcare utilization among older adults with COPD and depression. Respiratory Medicine 129, pages 53-58.
Crossref
Crossref
Idir Hamdidouche, Vincent Jullien, Pierre Boutouyrie, Eliane Billaud, Michel Azizi & Stéphane Laurent. (2017) Drug adherence in hypertension. Journal of Hypertension 35:6, pages 1133-1144.
Crossref
Crossref
Alberto Mazza, Salvatore Lenti, Laura Schiavon, Antonella Paola Sacco, Fabio Dell’Avvocata, Gianluca Rigatelli & Emilio Ramazzina. (2017) Fixed-Dose Triple Combination of Antihypertensive Drugs Improves Blood Pressure Control: From Clinical Trials to Clinical Practice. Advances in Therapy 34:4, pages 975-985.
Crossref
Crossref
Andrea L. Schaffer, Sallie-Anne Pearson & Nicholas A. Buckley. (2016) How does prescribing for antihypertensive products stack up against guideline recommendations? An Australian population-based study (2006-2014). British Journal of Clinical Pharmacology 82:4, pages 1134-1145.
Crossref
Crossref
François Després, Amélie Forget, Fatima-Zohra Kettani & Lucie Blais. (2016) Impact of Patient Reimbursement Timing and Patient Out-of-Pocket Expenses on Medication Adherence in Patients Covered by Private Drug Insurance Plans. Journal of Managed Care & Specialty Pharmacy 22:5, pages 539-547.
Crossref
Crossref
O. V. Machilskaya. (2016) The factors determining adherence to treatment in arterial hypertension patients (literature review). Kardiologiya i serdechno-sosudistaya khirurgiya 9:3, pages 55.
Crossref
Crossref
Yasunari Mano, Shota Fukushima, Hisayuki Kuroda, Hiroyuki Ohshima, Yoshinori Kato, Kaori Ohuchi, Kayoko Maezawa, Yasuyuki Momose, Shunya Ikeda & Mariko Asahi. (2015) Adherence to changing from brand-name to generic atorvastatin in newly treated patients: a retrospective cohort study using health insurance claims. Journal of Pharmaceutical Health Care and Sciences 1:1.
Crossref
Crossref
Stéphane Laurent. (2015) Achieving Goal Blood Pressure. High Blood Pressure & Cardiovascular Prevention 22:S1, pages 5-9.
Crossref
Crossref
Lynda McEvoy. (2015) Hypertension Care: It’s Time to Act. EMJ Cardiology, pages 2-10.
Crossref
Crossref
Ai Theng Cheong, Salmiah Mohd Said & Norliza Muksan. (2013) Time to Achieve First Blood Pressure Control After Diagnosis Among Hypertensive Patients at Primary Health Care Clinics. Asia Pacific Journal of Public Health 27:2, pages NP485-NP494.
Crossref
Crossref
Robert J. Romanelli & Jodi B. Segal. (2014) Predictors of Statin Compliance after Switching from Branded to Generic Agents among Managed-Care Beneficiaries. Journal of General Internal Medicine 29:10, pages 1372-1378.
Crossref
Crossref
François Després, Sylvie Perreault, Lyne Lalonde, Amélie Forget, Fatima-Zohra Kettani & Lucie Blais. (2014) Impact of Drug Plans on Adherence to and the Cost of Antihypertensive Medications Among Patients Covered by a Universal Drug Insurance Program. Canadian Journal of Cardiology 30:5, pages 560-567.
Crossref
Crossref
V N Shishkova. (2014) Place of arterial hypertension in brain lesion development - from minor cognitive disorders to dementia. Systemic Hypertension 11:1, pages 45-51.
Crossref
Crossref
M.H.D. Wasem Alsabbagh, Mark Lemstra, Dean Eurich, Lisa M. Lix, Thomas W. Wilson, Erin Watson & David F. Blackburn. (2014) Socioeconomic Status and Nonadherence to Antihypertensive Drugs: A Systematic Review and Meta-Analysis. Value in Health 17:2, pages 288-296.
Crossref
Crossref
A. Lawrence Gould, S. Unniachan & D. Wu. (2014) Indirect treatment comparison between fixed-dose-combinations of amlodipine/losartan and amlodipine/valsartan in blood pressure control. International Journal of Clinical Practice 68:2, pages 163-172.
Crossref
Crossref
Jingjing Qian, Linda Simoni‐Wastila, Gail B. Rattinger, Ilene H. Zuckerman, Susan Lehmann, Yu‐Jung J. Wei & Bruce Stuart. (2013) Association between depression and maintenance medication adherence among Medicare beneficiaries with chronic obstructive pulmonary disease. International Journal of Geriatric Psychiatry 29:1, pages 49-57.
Crossref
Crossref
Manabu Akazawa & Katsushi Fukuoka. (2013) Economic impact of switching to fixed-dose combination therapy for Japanese hypertensive patients: a retrospective cost analysis. BMC Health Services Research 13:1.
Crossref
Crossref
Benjamin J. Epstein, Niren K. Shah & Nancy L. Borja-Hart. (2013) Management of hypertension with fixed-dose triple-combination treatments. Therapeutic Advances in Cardiovascular Disease 7:5, pages 246-259.
Crossref
Crossref
Joel M. Neutel & David H. G. Smith. (2013) Hypertension Management: Rationale for Triple Therapy Based on Mechanisms of Action. Cardiovascular Therapeutics 31:5, pages 251-258.
Crossref
Crossref
Keith C. Ferdinand & Samar A. Nasser. (2013) A Review of the Efficacy and Tolerability of Combination Amlodipine/Valsartan in Non-White Patients with Hypertension. American Journal of Cardiovascular Drugs 13:5, pages 301-313.
Crossref
Crossref
Michel BurnierGregoire WuerznerHarry Struijker-BoudierJohn Urquhart. (2013) Measuring, Analyzing, and Managing Drug Adherence in Resistant Hypertension. Hypertension 62:2, pages 218-225.
Crossref
Crossref
Andrew J. Lewin, Joseph L. IzzoJrJr, Michael Melino, James Lee, Victor Fernandez & Reinilde Heyrman. (2013) Combined Olmesartan, Amlodipine, and Hydrochlorothiazide Therapy in Randomized Patients with Hypertension: A Subgroup Analysis of the TRINITY Study by Age. Drugs & Aging 30:7, pages 549-560.
Crossref
Crossref
Karly P. Garnock-Jones. (2013) Irbesartan/Amlodipine: A Review of its Use in Adult Patients with Essential Hypertension Not Adequately Controlled with Monotherapy. American Journal of Cardiovascular Drugs 13:2, pages 141-150.
Crossref
Crossref
Chiara Recarti & Thomas Unger. (2013) Prevention of Coronary Artery Disease: Recent Advances in the Management of Hypertension. Current Atherosclerosis Reports 15:3.
Crossref
Crossref
Carlos M. Ferrario, Sumeet Panjabi, Paul Buzinec & Jason P. Swindle. (2013) Clinical and economic outcomes associated with amlodipine/renin–angiotensin system blocker combinations. Therapeutic Advances in Cardiovascular Disease 7:1, pages 27-39.
Crossref
Crossref
Sumeet Panjabi, Michael Lacey, Timothy Bancroft & Felix Cao. (2013) Treatment adherence, clinical outcomes, and economics of triple-drug therapy in hypertensive patients. Journal of the American Society of Hypertension 7:1, pages 46-60.
Crossref
Crossref
Linda Simoni-Wastila, Jingjing Qian, Yu-Jung Jenny Wei, Bruce Stuart, Ilene H Zuckerman, Thomas Shaffer, Anand A Dalal & Lynda Bryant-Comstock. (2012) Should Medicare rely on high drug spending as a criterion for medication therapy management programmes?. Journal of Pharmaceutical Health Services Research 3:4, pages 213-219.
Crossref
Crossref
Abdul Ali Abdellatif. (2012) Role of Single‐Pill Combination Therapy in Optimizing Blood Pressure Control in High‐Risk Hypertension Patients and Management of Treatment‐Related Adverse Events. The Journal of Clinical Hypertension 14:10, pages 718-726.
Crossref
Crossref
Linda Simoni-Wastila, Yu-Jung Wei, Jingjing Qian, Ilene H. Zuckerman, Bruce Stuart, Thomas Shaffer, Anand A. Dalal & Lynda Bryant-Comstock. (2012) Association of Chronic Obstructive Pulmonary Disease Maintenance Medication Adherence With All-Cause Hospitalization and Spending in a Medicare Population. The American Journal of Geriatric Pharmacotherapy 10:3, pages 201-210.
Crossref
Crossref
Ludovit Paulis, Ulrike M. Steckelings & Thomas Unger. (2012) Key advances in antihypertensive treatment. Nature Reviews Cardiology 9:5, pages 276-285.
Crossref
Crossref
Denis Y. Ishisaka, Trevor Jukes, Robert J. Romanelli, Ken S. Wong & Timothy A. Schiro. (2012) Disparities in adherence to and persistence with antihypertensive regimens: an exploratory analysis from a community-based provider network. Journal of the American Society of Hypertension 6:3, pages 201-209.
Crossref
Crossref
Samir G Mallat. (2012) What is a preferred angiotensin II receptor blocker-based combination therapy for blood pressure control in hypertensive patients with diabetic and non-diabetic renal impairment?. Cardiovascular Diabetology 11:1, pages 32.
Crossref
Crossref
. (2011) Current World Literature. Current Opinion in Nephrology & Hypertension 20:5, pages 561-571.
Crossref
Crossref